COVID-19 vaccination and cancer immunotherapy: should they stick together?

The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is that caution should be exercised when combining both treatments.

Automated summary

The combination of COVID-19 vaccination and immunotherapy by checkpoint inhibitors in cancer patients may intensify immunological stimulation with potential reciprocal benefits, but caution should be exercised due to possible adverse events that can arise in each treatment modality.